Seventure Partners (France)

Seventure Partners is a Paris-based life sciences venture capital firm focused on seed through growth equity investments in biopharmaceutical, nutrition science, microbiome, and health technology companies primarily in France and the broader European market. The firm manages more than $1 billion in assets and invests with initial checks from $2 million to $10 million. Seventure is particularly recognized for its early and deep focus on the gut microbiome as a therapeutic target. Portfolio companies include Enterome, the French microbiome-based therapeutics company; Maat Pharma, the French company developing microbiome-based therapies for haematological cancers; Carbiotix, the Swedish prebiotic nutrition company; and Metabogen, a microbiome-based therapeutics company. Beyond its original investments, the portfolio includes additional European life sciences and microbiome companies.